Pain localization and response to botulinum toxin in cervical dystonia.

Dystonia Pub Date : 2025-07-09 DOI:10.3389/dyst.2025.14652
Alexander S Wang, Hanieh Agharazi, Aetan Parmar, Camilla W Kilbane, Lauren Cameron, Aasef G Shaikh, Steven A Gunzler
{"title":"Pain localization and response to botulinum toxin in cervical dystonia.","authors":"Alexander S Wang, Hanieh Agharazi, Aetan Parmar, Camilla W Kilbane, Lauren Cameron, Aasef G Shaikh, Steven A Gunzler","doi":"10.3389/dyst.2025.14652","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pain is a common symptom of cervical dystonia (CD). The mainstay of treatment of CD is botulinum toxin, which is known to have benefits in relieving pain. We aimed to characterize the locations of pain in patients with CD, and to assess what factors may predict pain reduction following botulinum toxin injection.</p><p><strong>Methods: </strong>We conducted a single-center observational study of CD patients who reported pain and who received botulinum toxin treatment. On the day of their toxin injection (in the untreated state), they filled out a survey evaluating primary and secondary sites of pain as indicated on a diagram, as well as Pain Numeric Rating Scale assessing average pain over the past 24 h. Two weeks later, they filled out a follow-up survey (in the treated state) to evaluate whether location and pain intensity changed.</p><p><strong>Results: </strong>55 people with CD participated in the study, and 40 of them completed both surveys. Most patients reported pain localization over the posterior musculature, especially in the areas overlying superior trapezius and levator scapulae. 21 of 40 (52.5%) patients reported improvement of pain intensity by ≥ 30% in the primary site of pain. The mean improvement in pain intensity was 30.4% (SD = 32.4%), with a mean improvement on Numeric Rating Scale of 2.13 (SD = 2.02). 68% of patients received injections into or close to their primary site of pain. Using univariate linear regression, there was no clear effect of age, sex, muscles injected, or TWSTRS motor subscale on the degree of pain improvement. The locations of pain remained relatively stable in the post-treatment state.</p><p><strong>Conclusion: </strong>We confirmed that botulinum toxin is effective for treatment of pain related to CD. We also gained insight into the typical locations of pain in CD by generating a heat map, showing pain most often in the regions of upper trapezius, levator scapulae, and splenius cervicus and capitis. Although there was not a significant correlation between the site of botulinum toxin injection and pain improvement, larger studies are needed to better determine optimal treatment strategies.</p>","PeriodicalId":72853,"journal":{"name":"Dystonia","volume":"4 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396148/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dystonia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/dyst.2025.14652","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Pain is a common symptom of cervical dystonia (CD). The mainstay of treatment of CD is botulinum toxin, which is known to have benefits in relieving pain. We aimed to characterize the locations of pain in patients with CD, and to assess what factors may predict pain reduction following botulinum toxin injection.

Methods: We conducted a single-center observational study of CD patients who reported pain and who received botulinum toxin treatment. On the day of their toxin injection (in the untreated state), they filled out a survey evaluating primary and secondary sites of pain as indicated on a diagram, as well as Pain Numeric Rating Scale assessing average pain over the past 24 h. Two weeks later, they filled out a follow-up survey (in the treated state) to evaluate whether location and pain intensity changed.

Results: 55 people with CD participated in the study, and 40 of them completed both surveys. Most patients reported pain localization over the posterior musculature, especially in the areas overlying superior trapezius and levator scapulae. 21 of 40 (52.5%) patients reported improvement of pain intensity by ≥ 30% in the primary site of pain. The mean improvement in pain intensity was 30.4% (SD = 32.4%), with a mean improvement on Numeric Rating Scale of 2.13 (SD = 2.02). 68% of patients received injections into or close to their primary site of pain. Using univariate linear regression, there was no clear effect of age, sex, muscles injected, or TWSTRS motor subscale on the degree of pain improvement. The locations of pain remained relatively stable in the post-treatment state.

Conclusion: We confirmed that botulinum toxin is effective for treatment of pain related to CD. We also gained insight into the typical locations of pain in CD by generating a heat map, showing pain most often in the regions of upper trapezius, levator scapulae, and splenius cervicus and capitis. Although there was not a significant correlation between the site of botulinum toxin injection and pain improvement, larger studies are needed to better determine optimal treatment strategies.

Abstract Image

Abstract Image

颈肌张力障碍的疼痛定位及对肉毒毒素的反应。
疼痛是颈肌张力障碍(CD)的常见症状。治疗乳糜泻的主要方法是肉毒杆菌毒素,它对缓解疼痛有好处。我们的目的是表征CD患者疼痛的部位,并评估哪些因素可以预测注射肉毒杆菌毒素后疼痛减轻。方法:我们对报告疼痛并接受肉毒杆菌毒素治疗的乳糜泻患者进行了单中心观察研究。在注射毒素当天(未治疗状态),他们填写了一份调查,评估了图表上显示的原发性和继发疼痛部位,以及评估过去24小时平均疼痛的疼痛数值评定量表。两周后,他们填写了一份随访调查(治疗状态),以评估位置和疼痛强度是否发生了变化。结果:55名乳糜泻患者参与了研究,其中40人完成了两项调查。大多数患者报告疼痛定位于后部肌肉组织,特别是在上斜方肌和肩胛提肌上覆区域。40例患者中有21例(52.5%)报告原发疼痛部位疼痛强度改善≥30%。疼痛强度平均改善30.4% (SD = 32.4%),数值评定量表平均改善2.13 (SD = 2.02)。68%的患者在原发疼痛部位或附近接受了注射。使用单变量线性回归,年龄、性别、注射肌肉或TWSTRS运动量表对疼痛改善程度没有明显影响。治疗后疼痛部位保持相对稳定。结论:我们证实肉毒杆菌毒素对治疗与CD相关的疼痛是有效的。我们还通过生成热图了解了CD中疼痛的典型部位,该热图显示疼痛最常发生在斜方肌上部、肩胛提肌、颈脾和头炎区域。虽然注射肉毒杆菌毒素的部位与疼痛改善之间没有显著的相关性,但需要更大规模的研究来更好地确定最佳治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信